| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/1995 | US5389529 Gene comprising DNA molecule encoding signal sequence altered to encode fourteen hydrophobic amino acids in core region |
| 02/14/1995 | US5389528 Isolated DNA sequence encoding polypeptide identifiable as component of hepatitis delta antigen |
| 02/14/1995 | US5389527 DNA encoding mammalian phosphodiesterases |
| 02/14/1995 | US5389526 Producing polypeptides which facilitate extrachromosomal replication or recominant plasmid carrying variety of genes and promoter sequences; culturing |
| 02/14/1995 | US5389525 DNA-molecules coding for FMDH control regions and structural gene for a protein having FMDH-activity and their use thereof |
| 02/14/1995 | US5389520 Specific detection of cell surface receptor leukocyte adhesion molecule-1 |
| 02/14/1995 | US5389518 Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof |
| 02/14/1995 | US5389515 Isolated nucleotide sequences for identifying Neisseria gonorrhoeae |
| 02/14/1995 | US5389514 Transfection; hybridization; converting uridine to cytidine by means of nuclear extract obtained from human or mammal or flies cells |
| 02/14/1995 | US5389513 Placing sample in nutrient medium, disrupting cells, denaturing released DNA, contacting with oligonucleotide to hybridize, detecting hybrid, correlating presence with that of Listeria monocytogenes |
| 02/14/1995 | US5389368 Avirulent microbes and uses therefor |
| 02/14/1995 | US5389069 Method and apparatus for in vivo electroporation of remote cells and tissue |
| 02/14/1995 | CA1334387C Feline leukemia virus vaccine |
| 02/14/1995 | CA1334386C Method for producing hepatitis b virus proteins in yeast |
| 02/14/1995 | CA1334385C Carrier for dna-hybridization |
| 02/12/1995 | CA2130202A1 Recombinant adenovirus vaccines |
| 02/11/1995 | CA2130210A1 Human trh receptor, its production and use |
| 02/10/1995 | CA2129812A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria in which they are present, and their use |
| 02/09/1995 | WO1995004162A2 Dna sequencing enzymes |
| 02/09/1995 | WO1995004160A1 Tag reagent and assay method |
| 02/09/1995 | WO1995004158A1 Use of heparanase to identify and isolate anti-heparanase compound |
| 02/09/1995 | WO1995004152A1 Dna, constructs, cells and plants derived therefrom |
| 02/09/1995 | WO1995004151A2 Vaccine compositions containing recombinant tetc-fusion proteins |
| 02/09/1995 | WO1995004150A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis |
| 02/09/1995 | WO1995004149A1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca |
| 02/09/1995 | WO1995004148A1 Process for the efficient production of 7-adca via 2-(carboxyethylthio)acetyl-7-adca and 3-(carboxymethylthio)propionyl-7-adca |
| 02/09/1995 | WO1995004147A1 Recombinant constructs using replacement sequences in hypervariable regions |
| 02/09/1995 | WO1995004146A2 Bacillus thuringiensis cryet4 and cryet5 toxin genes and proteins toxic to lepidopteran insects |
| 02/09/1995 | WO1995004145A1 Novel b. burgdorferi polypeptides |
| 02/09/1995 | WO1995004144A1 Dna encoding a human calcium channel alpha-1e subunit |
| 02/09/1995 | WO1995004142A2 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | WO1995004141A1 Antisense oligonucleotides against herpes simplex virus types 1 and 2 |
| 02/09/1995 | WO1995004140A1 Process for isolating nucleic acid from gram positive microorganisms |
| 02/09/1995 | WO1995004139A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | WO1995004133A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | WO1995004081A1 MONOCLONAL IgA ANTIBODY AGAINST RESPIRATORY SYNCYTIAL VIRUS |
| 02/09/1995 | WO1995004080A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | WO1995004079A1 Recombinant vector containing a lipoprotein gene sequence for expressing nucleotide sequences |
| 02/09/1995 | WO1995004076A1 Expression of fusion polypeptides transported out of the cytoplasm without leader sequences |
| 02/09/1995 | WO1995004075A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | WO1995004074A1 THE ESCHERICHIA COLI csrA GENE, PROTEIN ENCODED THEREBY, AND METHODS OF USE THEREOF |
| 02/09/1995 | WO1995004073A1 Type-2 angiotensin ii receptor and gene |
| 02/09/1995 | WO1995004069A1 Biotinylation of proteins |
| 02/09/1995 | WO1995004064A1 Polynucleotide decoys that ihnibit mhc-ii expression and uses thereof |
| 02/09/1995 | WO1995003834A1 PRE-BINDING OF RETROVIRAL VECTOR PARTICLES WITH COMPLEMENT COMPONENTS TO ENABLE THE PERFORMANCE OF HUMAN GENE THERAPY $i(IN VIVO) |
| 02/09/1995 | WO1995003833A1 Oligomers for modulating protein kinase c |
| 02/09/1995 | WO1995003832A1 Intracellular immunization |
| 02/09/1995 | WO1995003831A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | WO1995003820A1 Transgenic, cross-linked hemoglobin |
| 02/09/1995 | WO1995003817A1 Method of treating reproductive disorders |
| 02/09/1995 | WO1995003788A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | WO1995003701A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | WO1995003694A1 Method for making universal donor cells |
| 02/09/1995 | WO1995003690A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures |
| 02/09/1995 | WO1995000645A3 Process for producing relaxin |
| 02/09/1995 | WO1994029450A3 Novel, recombinantly produced spider silk analogs |
| 02/09/1995 | CA2168790A1 Method of treating reproductive disorders |
| 02/09/1995 | CA2168647A1 Monogenous preparations of cytotoxic conjugates |
| 02/09/1995 | CA2168471A1 Dna sequencing enzymes |
| 02/09/1995 | CA2168431A1 Process for the efficient production of 7-adca via 2-(carboxyethylthio)acetyl-7-adca and 3(carboxymethylthio)propionyl-7-adca |
| 02/09/1995 | CA2168430A1 Hmg2 promoter expression system and post-harvest production of gene products in plants and plant cell cultures |
| 02/09/1995 | CA2168426A1 Recombinant vector containing a lipoprotein gene sequence expressing nucleotide sequences |
| 02/09/1995 | CA2168349A1 Intracellular immunization |
| 02/09/1995 | CA2168261A1 Haemopoietic growth factor antagonists |
| 02/09/1995 | CA2168245A1 Polynucleotide decoys that inhibit mhc-ii expression and uses thereof |
| 02/09/1995 | CA2168243A1 Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use |
| 02/09/1995 | CA2168230A1 Human antibodies against varicella-zoster virus |
| 02/09/1995 | CA2168098A1 Jak kinases and regulation of cytokine signal transduction |
| 02/09/1995 | CA2168008A1 Escherichia coli csra gene, protein encoded thereby, and methods of use thereof |
| 02/09/1995 | CA2168004A1 Process for the efficient production of 7-adca via 3-(carboxyethylthio)propionyl-7-adca |
| 02/09/1995 | CA2167938A1 Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
| 02/09/1995 | CA2167835A1 Monoclonal iga antibody against respiratory syncytial virus |
| 02/09/1995 | CA2167706A1 Modified dna virus vectors and uses therefor |
| 02/09/1995 | CA2167680A1 Antisense oligonucleotide inhibition of vascular endothelial growth factor expression |
| 02/09/1995 | CA2166995A1 Transgenic, cross-linked hemoglobin |
| 02/08/1995 | EP0637631A2 Highly efficient expression of a polypeptide containing a modified preS1 region of the major hepatitis B virus antigen |
| 02/08/1995 | EP0637630A2 Method for the biological synthesis of peptides |
| 02/08/1995 | EP0637593A1 Bispecific trigger molecules recognizing lymphocyte antigen CD2 and tumor antigens |
| 02/08/1995 | EP0637591A2 A novel expression vector for phytolacca antiviral protein |
| 02/08/1995 | EP0637342A1 Process for typing of hcv isolates |
| 02/08/1995 | EP0637341A1 A predictive assay for suicidal behavior |
| 02/08/1995 | EP0637339A1 Dna constructs and plants incorporating them |
| 02/08/1995 | EP0637338A1 Dna, dna constructs, cells and plants derived therefrom |
| 02/08/1995 | EP0637337A1 Recombinant antigen containing in its sequence a heterologous immunostimulatory domain-use as a vaccine |
| 02/08/1995 | EP0637336A1 Mn gene and protein |
| 02/08/1995 | EP0637335A1 Recombinant mutants for inducing specific immune responses |
| 02/08/1995 | EP0637334A1 Peptides having a gdp exchange factor activity, nucleic acid sequences coding for said peptides, preparation and utilization |
| 02/08/1995 | EP0637333A1 Ifn receptors recognition factors, protein sequences and methods of use thereof |
| 02/08/1995 | EP0637318A1 Peptide derivatives corresponding to the carboxy terminal sequence of hirudin |
| 02/08/1995 | EP0637316A1 Antisense oligonucleotide inhibition of papillomavirus |
| 02/08/1995 | EP0637237A1 Calcium receptor-active molecules |
| 02/08/1995 | EP0637201A1 Method for inducing tumor immunity |
| 02/08/1995 | EP0601117A4 SYNTHETIC tRNAs. |
| 02/08/1995 | EP0386222B1 Process for preparing human serum albumine by fermenting a genetically engineered microorganism in the presence of a polyalkylene compound |
| 02/08/1995 | CN1098436A Cell specific necrosis |
| 02/08/1995 | CN1098416A Process for producing hydrophobic polypeptides, proteins or peptides |
| 02/07/1995 | USRE34851 Biosynthesis of 2 keto-L-gulonic acid |
| 02/07/1995 | US5387758 Production of improved rapeseed exhibiting a reduced saturated fatty acid content |
| 02/07/1995 | US5387757 Genetic engineering |
| 02/07/1995 | US5387756 Modification of plant metabolism |